rs2293576

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001128225.3(SLC39A13):​c.573G>A​(p.Ala191Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.32 in 1,613,866 control chromosomes in the GnomAD database, including 87,445 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5897 hom., cov: 33)
Exomes 𝑓: 0.33 ( 81548 hom. )

Consequence

SLC39A13
NM_001128225.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.557

Publications

57 publications found
Variant links:
Genes affected
SLC39A13 (HGNC:20859): (solute carrier family 39 member 13) This gene encodes a member of the LIV-1 subfamily of the ZIP transporter family. The encoded transmembrane protein functions as a zinc transporter. Mutations in this gene have been associated with the spondylocheiro dysplastic form of Ehlers-Danlos syndrome. Alternate transcript variants have been found for this gene. [provided by RefSeq, Jan 2016]
SLC39A13 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, spondylocheirodysplastic type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P, Orphanet, Genomics England PanelApp
  • spondyloepimetaphyseal dysplasia-abnormal dentition syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 11-47413435-G-A is Benign according to our data. Variant chr11-47413435-G-A is described in ClinVar as Benign. ClinVar VariationId is 384707.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.557 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.436 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC39A13NM_001128225.3 linkc.573G>A p.Ala191Ala synonymous_variant Exon 5 of 10 ENST00000362021.9 NP_001121697.2 Q96H72-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC39A13ENST00000362021.9 linkc.573G>A p.Ala191Ala synonymous_variant Exon 5 of 10 1 NM_001128225.3 ENSP00000354689.4 Q96H72-1

Frequencies

GnomAD3 genomes
AF:
0.249
AC:
37789
AN:
152046
Hom.:
5899
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0618
Gnomad AMI
AF:
0.298
Gnomad AMR
AF:
0.230
Gnomad ASJ
AF:
0.347
Gnomad EAS
AF:
0.367
Gnomad SAS
AF:
0.452
Gnomad FIN
AF:
0.262
Gnomad MID
AF:
0.250
Gnomad NFE
AF:
0.334
Gnomad OTH
AF:
0.291
GnomAD2 exomes
AF:
0.310
AC:
77694
AN:
250940
AF XY:
0.325
show subpopulations
Gnomad AFR exome
AF:
0.0597
Gnomad AMR exome
AF:
0.191
Gnomad ASJ exome
AF:
0.345
Gnomad EAS exome
AF:
0.373
Gnomad FIN exome
AF:
0.266
Gnomad NFE exome
AF:
0.335
Gnomad OTH exome
AF:
0.322
GnomAD4 exome
AF:
0.327
AC:
478352
AN:
1461700
Hom.:
81548
Cov.:
57
AF XY:
0.332
AC XY:
241608
AN XY:
727170
show subpopulations
African (AFR)
AF:
0.0529
AC:
1772
AN:
33476
American (AMR)
AF:
0.197
AC:
8806
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.350
AC:
9143
AN:
26126
East Asian (EAS)
AF:
0.308
AC:
12222
AN:
39692
South Asian (SAS)
AF:
0.451
AC:
38874
AN:
86246
European-Finnish (FIN)
AF:
0.270
AC:
14435
AN:
53404
Middle Eastern (MID)
AF:
0.306
AC:
1763
AN:
5764
European-Non Finnish (NFE)
AF:
0.334
AC:
371700
AN:
1111898
Other (OTH)
AF:
0.325
AC:
19637
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
21042
42083
63125
84166
105208
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11894
23788
35682
47576
59470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.248
AC:
37780
AN:
152166
Hom.:
5897
Cov.:
33
AF XY:
0.248
AC XY:
18424
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.0617
AC:
2561
AN:
41528
American (AMR)
AF:
0.231
AC:
3528
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.347
AC:
1205
AN:
3470
East Asian (EAS)
AF:
0.366
AC:
1892
AN:
5164
South Asian (SAS)
AF:
0.452
AC:
2181
AN:
4826
European-Finnish (FIN)
AF:
0.262
AC:
2776
AN:
10592
Middle Eastern (MID)
AF:
0.248
AC:
73
AN:
294
European-Non Finnish (NFE)
AF:
0.334
AC:
22682
AN:
67966
Other (OTH)
AF:
0.288
AC:
610
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1398
2797
4195
5594
6992
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
406
812
1218
1624
2030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.315
Hom.:
15735
Bravo
AF:
0.234
Asia WGS
AF:
0.393
AC:
1367
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Sep 30, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 25, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Ehlers-Danlos syndrome, spondylocheirodysplastic type Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
5.4
DANN
Benign
0.85
PhyloP100
0.56
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2293576; hg19: chr11-47434986; COSMIC: COSV61521013; COSMIC: COSV61521013; API